Clinical Trial Update: RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating a RANKL-blockade for erosive osteoarthritis of the interphalangeal finger joints has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erosive Osteoarthritis of the Interphalangeal Joints
• Hand Osteoarthritis

Drugs mentioned

• RANKL-blockade

Snippet

Sponsor: University Hospital, Ghent | Conditions: Hand Osteoarthritis | Phase 2 | Status: COMPLETED | Results posted: 2024-09-25